Abstract: Quantification of the scar volume and scar percentage by cardiovascular magnetic resonance (CMR) is superior to traditional metrics like left ventricular end-diastolic volume (LVEDV), left ventricular end-systolic volume (LVESV), and left ventricular ejection fraction (LVEF) in prognosticating the future likelihood of the development of cardiovascular events in patients with ischemic cardiomyopathy (ICM).
Introduction
In patients with ischemic cardiomyopathy (ICM)—heart muscle disease caused by restricted blood flow—clinicians traditionally rely on "descriptors of dysfunction" to predict a patient's future. The most common metrics are Left Ventricular Ejection Fraction (LVEF) and heart volumes (LVEDV/LVESV). However, these metrics are often blunt instruments; two patients can have the same low LVEF, yet experience vastly different clinical outcomes. This study hypothesized that the underlying "substrate" of the disease—the actual scar tissue left behind by previous heart attacks—holds the key to better prognosis.
Methods
The researchers followed 86 patients with ICM and low LVEF (<50%) for an average of 20 months. Each patient underwent a 1.5-Tesla CMR scan using Late Gadolinium Enhancement (LGE). Gadolinium contrast washes out of healthy heart muscle quickly but lingers in scarred or fibrotic tissue, allowing researchers to visualize and quantify scars with high precision.
The quantification process involved:
- Scar Volume: Calculated by tracing hyper-enhanced areas across multiple heart "slices" from base to apex.
- Scar Percentage: The ratio of scar volume to total myocardial volume.
- Transmurality: Grading how deep the scar penetrated the heart wall across a 72-segment model.
Key Insights and Results
During the follow-up, 33 patients (38%) experienced cardiovascular events. A primary finding was that traditional metrics (LVEF, LVEDV, LVESV) were statistically identical between patients who had future events and those who didn't. Only the scar metrics showed a significant difference:
- Scar Volume: 16.8 cm³ in the event group vs. 11.7 cm³ in the no-event group (p = 0.023).
- Scar Percentage: 10.2% in the event group vs. 7.2% in the no-event group (p = 0.037).
Notably, scar metrics provided unique data points independent of pumping power. As shown in the correlation analysis, scar volume and percentage did not correlate strongly with LVEF, meaning a heart can be severely scarred while maintaining a relatively stable ejection fraction.
Additionally, the study highlighted the danger of the "gray zone." Patients who suffered events had a higher number of non-transmural segments (scars that don't penetrate the full wall thickness). This supports the theory that surviving muscle fibers within a scar can create electrical circuits that trigger fatal arrhythmias.
Conclusion
The study concludes that CMR-based tissue composition analysis is a more potent predictor of risk than traditional pumping metrics. Quantifying myocardial scars offers a longitudinal prognostic marker that could assist clinicians in identifying high-risk patients who may benefit from more aggressive interventions, such as Implantable Cardioverter Defibrillators (ICDs). While limited by a relatively small sample size, the findings suggest a shift toward substrate-based risk assessment in ischemic heart disease.
Summary updated